rs141553540
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000733.4(CD3E):c.580G>A(p.Gly194Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000342 in 1,613,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000733.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD3E | ENST00000361763.9 | c.580G>A | p.Gly194Ser | missense_variant | Exon 9 of 9 | 1 | NM_000733.4 | ENSP00000354566.4 | ||
CD3E | ENST00000528600.1 | c.562G>A | p.Gly188Ser | missense_variant | Exon 7 of 7 | 5 | ENSP00000433975.1 | |||
CD3E | ENST00000526146.5 | n.1966G>A | non_coding_transcript_exon_variant | Exon 7 of 7 | 2 | |||||
CD3E | ENST00000531913.1 | n.951G>A | non_coding_transcript_exon_variant | Exon 4 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151818Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249702Hom.: 0 AF XY: 0.0000667 AC XY: 9AN XY: 135000
GnomAD4 exome AF: 0.000367 AC: 537AN: 1461458Hom.: 0 Cov.: 31 AF XY: 0.000345 AC XY: 251AN XY: 726960
GnomAD4 genome AF: 0.0000988 AC: 15AN: 151818Hom.: 0 Cov.: 30 AF XY: 0.0000405 AC XY: 3AN XY: 74144
ClinVar
Submissions by phenotype
Immunodeficiency 18 Uncertain:3
CD3E NM_000733.3 exon 9 p.Gly194Ser (c.580G>A): This variant has not been reported in the literature but is present in 0.01% (13/127910) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-118186213-G-A). This variant is present in ClinVar (Variation ID:302664). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 194 of the CD3E protein (p.Gly194Ser). This variant is present in population databases (rs141553540, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CD3E-related conditions. ClinVar contains an entry for this variant (Variation ID: 302664). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at